Publication | Closed Access

Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease

Inhibitory ActivityMedicinal ChemistryAlzheimer's DiseaseMedicineSelective Acetylcholinesterase InhibitorsPharmacological AgentNeuropharmacologyNeurochemical BiomarkersBiological EvaluationNeurologyDrug DevelopmentPharmacologyPharmaceutical ChemistryNovel Tryptanthrin DerivativesDrug Discovery